Загрузка...
Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects
Recent studies have highlighted the successes of chimeric antigen receptor-modified T- (CART-) cell-based therapy for B-cell malignancies, and early phase clinical trials have been launched in recent years. The few published clinical studies of CART cells in solid tumors have addressed safety and fe...
Сохранить в:
| Опубликовано в: : | J Immunol Res |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4779545/ https://ncbi.nlm.nih.gov/pubmed/26998495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/3850839 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|